Why the study?
Does medium chain triglyceride feed improve blood lipid levels in a neonate with primary chylomicronemia?
Does medium chain triglyceride feed improve blood lipid levels in a neonate with primary chylomicronemia?
Dietary management with medium chain triglycerides is highly effective in normalizing lipid levels in infantile chylomicronemia caused by novel LPL gene mutations.
Supports MCT feeding in neonatal chylomicronemia; leaves open confirmation in controlled LPL-mutation studies.
Monogenic disorders affecting the lipid metabolism are rare, but early diagnosis is important to ensure prompt initiation of management. Case Report: A three-week old neonate presenting with rectal bleeding was found to have blood of an unusual cream-like appearance. Significant lipemia was confirmed, with massive increase in triglyceride and cholesterol levels. Centrifugation confirmed chylomicronemia. Primary chylomicronemia is extremely rare and most commonly caused by a lipoprotein lipase (LPL) gene mutation. The infant was a compound heterozygous for two deletions in the LPL gene: p. Thr45HisfsX3, and the here for the first time described p. Phe189X, both leading to a premature stop codon the absence of a mature protein. Subsequent change to medium chain triglyceride feed resulted in near-normal blood lipid levels. Conclusion: Novel mutations affecting chylomicron metabolism continue to be identified and may affect patients of ethnic background considered low-risk. This case illustrates that adequate treatment and dietary management is highly effective in symptomatic management, and in preventing serious complications in both infancy and later in life.
No takes yet. Share an insight, caveat, or question.
Felsenstein et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: